$138.0 Million
OptiNose AS
Initial Public Offering
Active Bookrunner
$136.9 Million
Menlo Therapeutics Inc.
Initial Public Offering
Active Bookrunner
$107.5 Million
Neuronetics, Inc.
Initial Public Offering
Active Bookrunner
$138.8 Million
Deciphera Pharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
$42.2 Million
ASLAN Pharmaceuticals Pte. Ltd.
Initial Public Offering
Active Bookrunner
$172.5 Million
Day One Biopharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$172.6 Million
Cogent Biosciences
Follow-On Offering
Active Bookrunner
$344.6 Million
Legend Biotech
Follow-On Offering
Active Bookrunner
$174.0 Million
Privia Health Group, Inc.
Follow-On Offering
Active Bookrunner
$144.2 Million
Fulcrum Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.